Boehringer raises hope of oral drug for diabetic eye disease
People living with diabetic macular oedema (DME) currently have to undergo regular injections into their eyes to treat the condition, but an oral alternative may be on the horizon. Boehringer Ingelheim has raised hopes of a more patient-friendly option …